Sort
51,593 grants matching “hepatitis”
Drug Therapies Identified through Modeling AT Deficiency in C Elegans
$403,484Gary Arthur Silverman · Washington University · P01 · FY2022 · DK
Reducing Vertical Transmission of Hepatitis B in Africa (REVERT-B Trial)
$403,480Jodie Ann Dionne · University Of Alabama At Birmingham · R01 · FY2022 · HD
Models for Optimal Liver Transplant Outcomes
$403,465Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2003 · DK
Effect of Oral Cimetidine in the Protoporphyrias (IND 153247 submitted 9/2/2020)
$403,457Amy Kathryn Dickey · Massachusetts General Hospital · R01 · FY2024 · FD
Effect of Oral Cimetidine in the Protoporphyrias (IND 153247 submitted 9/2/2020)
$403,457Amy Kathryn Dickey · Massachusetts General Hospital · R01 · FY2023 · FD
Field-deployable platform for prognostic hepatic cancer screening in low-resource settings
$403,427Marc D Porter · University Of Utah · UG3 · FY2018 · CA
Mechanisms of xenobiotic-induced biliary inflammation and fibrosis
$403,406James P Luyendyk · University Of Kansas Medical Center · R01 · FY2010 · ES
Dendritic Cell-Associated C-Type Lectins
$403,380Edward A Clark · University Of Washington · R01 · FY2013 · AI
Therapeutic Potential of Estrogen-Regulated Metabolism and Cardiovascular Risk
$403,338John Micheal Stafford · Vanderbilt University Medical Center · R01 · FY2024 · DK
Maintenance vs Programming in Th1 Memory Cell Development in P. Chabaudi Malaria
$403,335Robin Stephens · University Of Texas Med Br Galveston · R01 · FY2015 · AI
Hepatitis B treatment and HIV Infection in resources limited settings
$403,334Chloe L Thio · Johns Hopkins University · R01 · FY2009 · AI
New Approaches to the Evaluation and Treatment of Acromegaly
$403,327Pamela U Freda · Columbia University Health Sciences · R01 · FY2011 · DK
FGFR Signaling in Liver Injury and Fibrosis
$403,299Nirmala Mavila · Cedars-Sinai Medical Center · R01 · FY2024 · DK
Biliary Atresia, Cholestatic Liver Diseases, and Cystic Fibrosis: Indiana Univers
$403,271Jean Pappas Molleston · Indiana University Indianapolis · U01 · FY2012 · DK
Role of T Regulatory Cells in Chronic Infection
$403,245Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Copper and iron in nutritional immunity
$403,233Michael J Petris · University Of Missouri-Columbia · R01 · FY2019 · DK
PATHOBIOLOGY OF HEPATIC EPITHELIA
$403,230Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2000 · DK
Crossing Borders: HIV and Substance use at the Gateway to North America
$403,208Kimberly C Brouwer · University Of California, San Diego · R01 · FY2012 · DA
Improved Mimotope Structures and Scaffolds for Prime-Boost Strategies
$403,161Ralf Wagner · Novartis Vaccines And Diagnostics, Inc. · P01 · FY2007 · AI
A Precision Targeted Therapeutics for Nonalcoholic Fatty Liver Disease
$403,158Wanqing Liu · Wayne State University · R01 · FY2024 · DK
CELLULAR GENES THAT CONTROL HCV REPLICATION
$403,153Scripps Research Institute · R01 · FY2005 · CA
Examining Epidemiology of Folate Status Attributable to Adolescent Alcohol Use
$403,126Julie May Croff · Osu Center For Health Sciences · P20 · FY2016 · GM
Immunity and Virus Disease
$403,125Univ Of Massachusetts Med Sch Worcester · R37 · FY2004 · AI
Viral Resistance to Antiviral Therapy for Hepatitis C
$403,079University Of Maryland Baltimore · M01 · FY2004 · RR
Role of SAMe in the Progression of Nonalcoholic Fatty Liver Disease
$403,076Shelly Chi-Loo Lu · Cedars-Sinai Medical Center · R01 · FY2024 · DK